Angus, Peter W.

The role of the gut microbiota in NAFLD

Leung, C., Rivera, L., Furness, J. B., & Angus, P. W. (2016) · Nature Reviews Gastroenterology & Hepatology

Gut microbiota and healthLiver Disease Diagnosis and Treatment

Cited by 1,020

Review article: sarcopenia in cirrhosis – aetiology, implications and potential therapeutic interventions

Sinclair, M., Gow, P. J., Grossmann, M., & Angus, P. W. (2016) · Alimentary Pharmacology & Therapeutics

Nutrition and Health in AgingLiver Disease and Transplantation

Cited by 316

Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial

Sinclair, M., Grossmann, M., Hoermann, R., Angus, P. W., & Gow, P. J. (2016) · Journal of Hepatology

Hormonal and reproductive studiesNutrition and Health in Aging

Cited by 269

Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products

Fernando, D. H., Forbes, J. M., Angus, P. W., & Herath, C. B. (2019) · International Journal of Molecular Sciences

Liver Disease Diagnosis and TreatmentAdvanced Glycation End Products research

Cited by 184

Epidemiology of primary biliary cirrhosis in Victoria, Australia: High prevalence in migrant populations

Sood, S., Gow, P. J., Christie, J. M., & Angus, P. W. (2004) · Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 140

Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD

Bruinstroop, E., Dalan, R., Cao, Y., Bee, Y. M., Chandran, K., Cho, L. W., Soh, S. B., Teo, E. K., Toh, S.-A., Leow, M. K. S., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism

Liver Disease Diagnosis and TreatmentThyroid Disorders and Treatments

Cited by 108

Dietary glycotoxins exacerbate progression of experimental fatty liver disease

Leung, C., Herath, C. B., Jia, Z., Goodwin, M., Mak, K. Y., Watt, M. J., Forbes, J. M., & Angus, P. W. (2014) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentAdvanced Glycation End Products research

Cited by 88

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease

Leung, C., Herath, C. B., Jia, Z., Andrikopoulos, S., Brown, B. E., Davies, M. J., Rivera, L. R., Furness, J. B., Forbes, J. M., & Angus, P. W. (2016) · World Journal of Gastroenterology

Liver Disease Diagnosis and TreatmentAdvanced Glycation End Products research

Cited by 80